Skip to main content
Clinical Trials/NCT06070259
NCT06070259
Not yet recruiting
Not Applicable

Examining Patient Involvement Patterns and Trends in Participation in Bone Cancer Clinical Trials

Power Life Sciences Inc.1 site in 1 country500 target enrollmentOctober 2024
ConditionsBone Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bone Cancer
Sponsor
Power Life Sciences Inc.
Enrollment
500
Locations
1
Primary Endpoint
Rate of patients who decide to enroll in a bone cancer clinical research.
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating the safety and effectiveness of novel treatments for this disease. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.

The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Registry
clinicaltrials.gov
Start Date
October 2024
End Date
October 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
  • Diagnosis of bone cancer
  • No prior treatment for bone cancer

Exclusion Criteria

  • Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
  • Enrolled in another research study
  • Inability to provide written informed consent

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in a bone cancer clinical research.

Time Frame: 3 months

Number of bone cancer study participants who remain in clinical study until completion.

Time Frame: 12 months

Study Sites (1)

Loading locations...

Similar Trials